NOLAN SEAN P. received a stock award from TAYSHA GENE THERAPIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/14/2026ACC: 0001569926-26-000002
+1.66M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.66M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.01M
Price / share
—
Trade value
—
% of position
48.5%
1/12/2026
2.08M→3.09M
Total
Net shares
+1.01M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/12/2026 | A · Award | +1.01M | — | — | 48.5% | 2.08M | 3.09M |
| Total | +1.01M | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
648K shares
Shares
+648K
Strike price
4.86
Held after
648K
Exercisable
—
1/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock648K shares | 1/12/2026 | A · Award | +648K | 4.86 | — | 648K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.54M
Total
1.54M indirect1.54M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.54M | Indirect |
| Total | 1.54M | 1.54M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported